Atlas Venture Announces $250 Million Biotech Opportunity Fund
- Posted by ISPE Boston
- On January 7, 2019
Atlas Venture, a leading venture capital firm investing in breakthrough biotech innovation, has announced the closing of its first Opportunity Fund, raising $250 million in an oversubscribed fundraise. With Atlas Venture Opportunity Fund I (AVOF I), the firm will invest in existing Atlas portfolio companies as they progress. “We are delighted and humbled by the […]
Read More